Initiator Pharma A/S (OSTO:INIT) EV-to-Revenue : (As of Jun. 14, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Initiator Pharma A/S EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Initiator Pharma A/S's enterprise value is kr549.07 Mil. Initiator Pharma A/S's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was kr0.00 Mil. Therefore, Initiator Pharma A/S's EV-to-Revenue for today is .

The historical rank and industry rank for Initiator Pharma A/S's EV-to-Revenue or its related term are showing as below:

OSTO:INIT's EV-to-Revenue is not ranked ^*
in the Biotechnology industry.
Industry Median: 7.93
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-14), Initiator Pharma A/S's stock price is kr10.30. Initiator Pharma A/S's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was kr0.00. Therefore, Initiator Pharma A/S's PS Ratio for today is .

Initiator Pharma A/S EV-to-Revenue Historical Data

The historical data trend for Initiator Pharma A/S's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Initiator Pharma A/S EV-to-Revenue Chart

Initiator Pharma A/S Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

Initiator Pharma A/S Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Initiator Pharma A/S's EV-to-Revenue

For the Biotechnology subindustry, Initiator Pharma A/S's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Initiator Pharma A/S's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Initiator Pharma A/S's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Initiator Pharma A/S's EV-to-Revenue falls into.

Initiator Pharma A/S EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Initiator Pharma A/S's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	549.074	/	0
	=

Initiator Pharma A/S's current Enterprise Value is kr549.07 Mil.
Initiator Pharma A/S's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

Initiator Pharma A/S (OSTO:INIT) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Initiator Pharma A/S's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	10.30	/	0
	=

Initiator Pharma A/S's share price for today is kr10.30.
Initiator Pharma A/S's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00.

Initiator Pharma A/S EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Initiator Pharma A/S's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Initiator Pharma A/S (OSTO:INIT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Initiator Pharma A/S (OSTO:INIT) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Co/ COBIS, Ole Maaloesvej 3, Copenhagen, DNK, 2200

Website

https://www.initiatorpharma.com

Initiator Pharma A/S is a clinical Stage Life Science company engaged in the research and development of various drugs targeting medical needs within the central and peripheral nervous system. The company's principal drug candidate is the IPED2015, a type of monoamine reuptake inhibitor (MRI) that has completed preclinical development for the treatment of erectile dysfunction in men. Its MRI drug candidates also include IPDP2015 for the treatment of depression; and IPNP2015 to treat neuropathic pain.

Initiator Pharma A/S (OSTO:INIT) Headlines

No Headlines